In the United States (U.S.) nearly $1.7 billion was spent on blood gas/electrolyte monitoring, pulmonary function assessment, and sleep apnea management products in 2004.  Growing at a healthy compound annual rate of 9.5%, sales of these products are expected to reach approximately $2.9 billion by the year 2010.

This dynamic report from Medtech Insight includes analyses of products and technologies, current and forecast markets, competitors, and opportunities in the U.S. blood gas/electrolyte monitoring products market, as well as the pulmonary function assessment and sleep apnea management products markets. 

Covered topics in this report include arterial blood gas sampling kits; bi-level positive airway pressure devices; capnography/end-tidal carbon dioxide monitoring products; central laboratory arterial blood gas/electrolyte analyzers; continuous positive airway pressure devices; disposable and reusable pulse oximetry sensors; invasive and noninvasive blood gas monitoring techniques; multiple sleep latency testing; oxygen monitoring products; point-of-care arterial blood gas/electrolyte analyzers and disposables; pulmonary exercise testing and metabolic assessment products; pulse oximetry monitors; sleep apnea diagnosis, monitoring, and treatment products; and spirometry systems.

TABLE OF CONTENTS AND LIST OF EXHIBITS

EXECUTIVE SUMMARY

i.   Blood Gas/Electrolyte Monitoring Products Market

a.  Arterial Blood Gas Sampling Kits

b.  Laboratory-Based Arterial Blood Gas/Electrolyte Analyzers

c.  Point-of-Care Blood Gas/Electrolyte Analysis Products

d.  Pulse Oximetry Monitors and Sensors

e.  Capnography Monitors and Accessories

f.   Oxygen Monitors/Analyzers and Sensors

ii.   Pulmonary Function Assessment Products Market

a.  Diagnostic Spirometry Products

b.  High-End Pulmonary Function Testing Products

c.  Pulmonary Exercise Testing and Metabolic Assessment Products

iii.  Sleep Apnea Management Products Market

a.  Diagnostic Sleep Apnea Management Products

b.  Sleep Apnea Management Monitoring Products

c.  Sleep Apnea Treatment Products

Exhibit ES-1:    Blood Gas/Electrolyte Monitoring, Pulmonary Function Assessment, and Sleep Apnea Management Products, Market Forecast, by Type, 2004-2010

Exhibit ES-2:    Blood Gas/Electrolyte Monitoring Products, Market Forecast, 2004-2010

Exhibit ES-3:    Arterial Blood Gas Sampling Kits, Market Forecast, 2004-2010

Exhibit ES-4:    Laboratory Blood Gas/Electrolyte Analyzers, Market Forecast, 2004-2010

Exhibit ES-5:    Point-of-Care Blood Gas/Electrolyte Analysis Products, Market Forecast, 2004-2010

Exhibit ES-6:    Pulse Oximetry Products, Market Forecast, 2004-2010

Exhibit ES-7:    Capnography Monitoring Products, Market Forecast, 2004-2010

Exhibit ES-8:    Oxygen Monitoring Products, Market Forecast, 2004-2010

Exhibit ES-9:    Pulmonary Function Assessment Products, Market Forecast, by Type, 2004-2010

Exhibit ES-10:   Diagnostic Spirometry Products, Market Forecast, 2004-2010

Exhibit ES-11:   High-End Pulmonary Function Testing Products, Market Forecast, 2004-2010

Exhibit ES-12:   Pulmonary Exercise Testing and Metabolic Assessment Products, Market Forecast, 2004-2010

Exhibit ES-13:   Sleep Apnea Management Products, Market Forecast, 2004-2010

Exhibit ES-14:   Polysomnography Products, Market Forecast, 2004-2010

Exhibit ES-15:   Sleep Apnea Monitoring Devices, Market Forecast,  2004-2010

Exhibit ES-16:   Sleep Apnea Treatment Devices, Market Forecast, 2004-2010

1. SELECTED RESPIRATORY DISEASES/DISORDERS

1.1 Adult Respiratory Distress Syndrome

1.1.1 Etiology

1.1.2 Epidemiology

1.2 Asthma

1.2.1 Etiology

1.2.2 Epidemiology

1.3 Chronic Obstructive Pulmonary Disease

1.3.1 Chronic Bronchitis

1.3.1.1 Etiology

1.3.1.2 Epidemiology

1.3.2 Emphysema

1.3.2.1 Etiology

1.3.2.2 Epidemiology

1.4 Cystic Fibrosis

1.4.1 Etiology

1.4.2 Epidemiology

1.5 Pneumonia

1.5.1 Etiology

1.5.2 Epidemiology

1.6 Respiratory Failure

1.6.1 Etiology

1.6.2 Epidemiology

1.7 Restrictive Lung Disease

1.7.1 Etiology

1.7.2 Epidemiology

1.8 Sleep Apnea

1.8.1 Etiology

1.8.2 Epidemiology

1.9 Tuberculosis

1.9.1 Etiology

1.9.2 Epidemiology

Exhibit 1-1:    Adult Respiratory Distress Syndrome, Selected Statistics

Exhibit 1-2:    Asthma, Selected Statistics

Exhibit 1-3:    Chronic Obstructive Pulmonary Disease, Selected Statistics

Exhibit 1-4:    Cystic Fibrosis, Selected Statistics

Exhibit 1-5:    Pneumonia, Selected Statistics

Exhibit 1-6:    Respiratory Failure, Selected Statistics

Exhibit 1-7:    Restrictive Lung Disease, Selected Statistics

Exhibit 1-8:    Sleep Apnea, Selected Statistics

Exhibit 1-9:    Tuberculosis, Selected Statistics

2. BLOOD GAS/ELECTROLYTE MONITORING PRODUCTS MARKET

2.1 Blood Gas/Electrolyte Monitoring Overview

2.1.1 Invasive and Noninvasive Blood Gas/Electrolyte Monitoring

2.2 Blood Gas/Electrolyte Monitoring Products Market

2.2.1 Arterial Blood Gas/Electrolyte Testing Segment

2.2.1.1 Arterial Blood Gas Sampling Kits

2.2.1.1.1 Products/Technologies

2.2.1.1.2 Market Forecast

2.2.1.1.3 Competitive Analysis

2.2.1.2 Laboratory-Based Arterial Blood Gas/Electrolyte Analyzers

2.2.1.2.1 Products/Technologies

2.2.1.2.2 Market Analysis

2.2.1.2.3 Competitive Analysis

2.2.1.3 Point-of-Care Blood Gas/Electrolyte Analysis Products

2.2.1.3.1 Products/Technologies

2.2.1.3.2 Market Forecast

2.2.1.3.3 Competitive Analysis

2.2.2 Pulse Oximetry Segment

2.2.2.1 Pulse Oximetry Monitors and Sensors

2.2.2.1.1 Products/Technologies

2.2.2.1.2 Market Forecast

2.2.2.1.3 Competitive Analysis

2.2.3 Capnography/End-Tidal Carbon Dioxide Monitoring Segment

2.2.3.1 Capnography Monitors and Accessories

2.2.3.1.1 Products/Technologies

2.2.3.1.2 Market Forecast

2.2.3.1.3 Competitive Analysis

2.2.4 Oxygen Monitoring Segment

2.2.4.1 Oxygen Monitors/Analyzers and Sensors

2.2.4.1.1 Products/Technologies

2.2.4.1.2 Market Forecast

2.2.4.1.3 Competitive Analysis

Exhibit 2-1:    Blood Gas/Electrolyte Monitoring Products, Market Forecast, 2004-2010

Exhibit 2-2:    Arterial Blood Gas/Electrolyte Testing Products, Market Forecast, 2004-2010

Exhibit 2-3:    2005, Selected Arterial Blood Gas Sampling Kits

Exhibit 2-4:    Arterial Blood Gas Sampling Kits, Market Forecast, 2004-2010

Exhibit 2-5:    2004, Arterial Blood Gas Sampling Kits Market, Share by Supplier

Exhibit 2-6:    2005, Selected Laboratory-Based Blood Gas/Electrolyte Analyzers

Exhibit 2-7:    Laboratory Blood Gas/Electrolyte Analyzers, Market Forecast, 2004-2010

Exhibit 2-8:    2004, Laboratory-Based Blood Gas/Electrolyte Analyzers Market, Share by Supplier

Exhibit 2-9:    2005, Selected Point-of-Care Blood Gas/Electrolyte Analyzers

Exhibit 2-10:  Point-of-Care Blood Gas/Electrolyte Analysis Products, Market Forecast, 2004-2010

Exhibit 2-11:  Point-of-Care Blood Gas/Electrolyte Analyzers, Market Forecast, 2004-2010

Exhibit 2-12:  Point-of-Care Blood Gas/Electrolyte Analysis Disposables, Market Forecast, 2004-2010

Exhibit 2-13:  2004, Point-of-Care Blood Gas/Electrolyte Analysis Products Market, Share by Supplier

Exhibit 2-14:  Selected Disadvantages of Transcutaneous Oximetry

Exhibit 2-15:  Selected Advantages of Pulse Oximetry

Exhibit 2-16:  Selected Limitations of Pulse Oximetry

Exhibit 2-17:  2005, Selected Pulse Oximetry Products

Exhibit 2-18:  Pulse Oximetry Products, Market Forecast, 2004-2010

Exhibit 2-19:  Pulse Oximetry Monitors, Market Forecast, 2004-2010

Exhibit 2-20:  Pulse Oximetry Sensors, Market Forecast, 2004-2010

Exhibit 2-21:  Disposable Pulse Oximetry Sensors, Market Forecast, 2004-2010

Exhibit 2-22:  Reusable Pulse Oximetry Sensors, Market Forecast, 2004-2010

Exhibit 2-23:  2004, Pulse Oximetry Products Market, Share by Supplier

Exhibit 2-24:  Advantages and Disadvantages of Mainstream and Sidestream Capnography Sampling

Exhibit 2-25:  2005, Selected Capnography Products

Exhibit 2-26:  Capnography Monitoring Products, Market Forecast, 2004-2010

Exhibit 2-27:  Capnography Monitors, Market Forecast, 2004-2010

Exhibit 2-28:  2004, Capnography Products Market, Share by Supplier

Exhibit 2-29:  Oxygen Monitoring Products, Market Forecast, 2004-2010

3. PULMONARY FUNCTION ASSESSMENT PRODUCTS MARKET

3.1 Pulmonary Function Testing Overview

3.1.1 Respiratory Disease/Disorder Applications

3.1.2 Non-Respiratory Disease/Disorder Applications

3.2 Pulmonary Function Assessment Products Market

3.2.1 Diagnostic Spirometry Products Segment

3.2.1.1 Products/Technologies

3.2.1.2 Market Forecast

3.2.1.3 Competitive Analysis

3.2.2 High-End Pulmonary Function Testing Products Segment

3.2.2.1 Products/Technologies

3.2.2.2 Market Forecast

3.2.2.3 Competitive Analysis

3.2.3 Pulmonary Exercise Testing and Metabolic Assessment Systems Segment

3.2.3.1 Products/Technologies

3.2.3.2 Market Forecast

3.2.3.3 Competitive Analysis

Exhibit 3-1:    Lung Volumes and Capacities

Exhibit 3-2:    Pulmonary Function Assessment Products, Market Forecast, by Type, 2004-2010

Exhibit 3-3:    Principal Values Measured Via Spirometry

Exhibit 3-4:    2005, Selected Diagnostic Spirometers

Exhibit 3-5:    Diagnostic Spirometry Products, Market Forecast, 2004-2010

Exhibit 3-6:    Diagnostic Spirometers, Market Forecast, 2004-2010

Exhibit 3-7:    2004, Diagnostic Spirometry Products Market, Share by Supplier

Exhibit 3-8:    Indications for Pulmonary Function Testing

Exhibit 3-9:    2005, Selected High-End Pulmonary Function Testing Systems

Exhibit 3-10:  High-End Pulmonary Function Testing Products, Market Forecast, 2004-2010

Exhibit 3-11:  High-End Pulmonary Function Testing Systems, Market Forecast, 2004-2010

Exhibit 3-12:  2004, High-End Pulmonary Function Testing Products Market, Share by Supplier

Exhibit 3-13:  2005, Selected Pulmonary Exercise Testing and Metabolic Assessment Products

Exhibit 3-14:  Pulmonary Exercise Testing and Metabolic Assessment Products, Market Forecast, 2004-2010

Exhibit 3-15:  Pulmonary Exercise Testing Systems, Market Forecast, 2004-2010

Exhibit 3-16:  Metabolic Assessment Systems, Market Forecast, 2004-2010

Exhibit 3-17:  2004, Metabolic Assessment and Pulmonary Exercise Testing Equipment Market, Share by Supplier

4. SLEEP APNEA MANAGEMENT PRODUCTS MARKET

4.1 Market for Sleep Apnea Management Devices

4.1.1 Diagnostic Products Segment

4.1.1.1 Sleep Laboratories

4.1.1.2 Multiple Sleep Latency Testing

4.1.1.3 Maintenance of Wakefulness Testing

4.1.1.4 Polysomnography Systems

4.1.1.4.1 Products/Technologies

4.1.1.4.2 Market Forecast

4.1.1.4.3 Competitive Analysis

4.1.2 Monitoring Products Segment

4.1.2.1 Sleep Apnea Monitoring Systems

4.1.2.1.1 Products/Technologies

4.1.2.1.2 Market Forecast

4.1.2.1.3 Competitive Analysis

4.1.3 Treatment Products Segment

4.1.3.1 Sleep Apnea Treatment Systems

4.1.3.1.1 Products/Technologies

4.1.3.1.2 Market Forecast

4.1.3.1.3 Competitive Analysis

Exhibit 4-1:    Sleep Apnea Management Products, Market Forecast, 2004-2010

Exhibit 4-2:    2005, Selected Polysomnography Products

Exhibit 4-3:    Polysomnography Products, Market Forecast, 2004-2010

Exhibit 4-4:    2004, Polysomnography Products Market, Share by Supplier

Exhibit 4-5:    2005, Selected Sleep Apnea Monitoring Devices

Exhibit 4-6:    Sleep Apnea Monitoring Devices, Market Forecast, 2004-2010

Exhibit 4-7:    2004, Sleep Apnea Monitoring Devices Market, Share by Supplier

Exhibit 4-8:    2005, Selected Positive Airway Pressure Devices

Exhibit 4-9:    Sleep Apnea Treatment Devices, Market Forecast, 2004-2010

Exhibit 4-10:  2004, Sleep Apnea Treatment Devices Market, Share by Supplier

5. COMPANY PROFILES

5.1   Abbott Point of Care/Abbott Medical Products Group/Abbott Laboratories

5.2   Bayer HealthCare AG/Bayer AG

5.3   CAS Medical Systems, Inc.

5.4   Ferraris Respiratory, Inc./Ferraris Group PLC

5.5   Masimo Corporation

5.6   Medical Graphics Corporation/Angeion Corporation

5.7   MIDMARK Diagnostics Group/MIDMARK Corporation

5.8   Mallinckrodt, Inc./Tyco Healthcare Group LP/Tyco International LTD

5.9   Radiometer America, Inc./Radiometer AS/Danaher Corporation

5.10 ResMed Corporation

5.11 Respironics, Inc.

5.12 Roche Diagnostics Corporation/F. Hoffmann-La Roche Ltd/Roche Group

5.13 Smiths Medical, Inc./Smiths Group PLC

5.14 Sunrise Medical, Inc.

5.15 VIASYS Healthcare, Inc.

5.16 Vital Signs, Inc.

5.17 Welch Allyn, Inc.

APPENDIX:  COMPANY LISTING

Copyright 2005, Medtech Insight, LLC